acrB外排泵突变改变肺炎克雷伯菌耐药性
该研究分析全球42种ARGs在肺炎克雷伯菌中的分布,发现acrB最广泛,介导至少12类抗生素耐药。对92株AcrB蛋白药物结合口袋突变进行AlphaFold2建模与分子动力学模拟,显示部分突变株结构不稳定或趋近野生型,且改变抗生素结合亲和力。
要点
- acrB是肺炎克雷伯菌中分布最广的耐药基因,介导至少12类抗生素耐药。
- 药物结合口袋突变可显著改变AcrB蛋白稳定性与抗生素结合亲和力。
- 监测AcrB结构变异可能有助于预测耐药模式并指导治疗决策。
核心结论
- AcrB是肺炎克雷伯菌多重耐药的关键驱动因子。
- AcrB药物结合口袋突变可显著影响蛋白稳定性与抗生素结合行为。
研究设计与样本
- 对全球肺炎克雷伯菌分离株中报告的42种抗生素耐药基因进行基因组分析以识别acrB的突出性。
- 评估92条AcrB蛋白序列相对于野生型菌株NCTC9637的药物结合口袋突变。
- 使用AlphaFold2生成从头蛋白结构并通过分子动力学模拟评估。
主要发现
- acrB是最广泛分布的抗生素耐药基因,赋予对至少12类抗生素的耐药性。
- 与野生型相比,NCTC9617、NCTC9645和NCTC13635三个分离株显示多个药物结合口袋突变。
- 分子动力学模拟显示NCTC9645结构显著不稳定,而NCTC13635趋近于野生型样构象。
- 对接分析表明结合口袋突变改变了抗生素结合亲和力,提示底物识别与转运可能改变。
关键数值与推荐
- 全球基因组分析覆盖42种抗生素耐药基因。
- AcrB蛋白序列分析纳入92条序列,参照野生型菌株NCTC9637。
- acrB介导对至少12类抗生素的耐药性。
临床怎么用
- 监测AcrB药物结合口袋的结构变异可能有助于预测新发耐药模式。
- 上述结构变异信息或可指导耐药革兰阴性菌感染的治疗决策与精准抗生素治疗。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: To investigate the global prevalence of the acrB efflux transporter among antibiotic resistance genes (ARGs) in Klebsiella pneumoniae and to determine how mutations within AcrB drug-binding pockets influence structural stability and antibiotic interactions. METHODS: A global genomic analysis of 42 ARGs reported in K. pneumoniae isolates worldwide was performed to identify the prominence of acrB. A total of 92 AcrB protein sequences were assessed for drug-binding pocket mutations relative to the wild-type strain NCTC9637. De novo protein structures were generated using AlphaFold2 and evaluated through molecular dynamics (MD) simulations. MD analyses were conducted with multiple antibiotics to assess the impact of pocket mutations on drug-binding affinities. RESULTS: acrB emerged as the most widely distributed ARG, conferring resistance to at least 12 antibiotic classes. Three isolates, NCTC9617, NCTC9645, and NCTC13635, displayed multiple drug-binding pocket mutations when compared with the wild type. MD simulations revealed marked structural instability in NCTC9645, while NCTC13635 showed convergence towards a wild-type-like conformation. Docking analyses demonstrated that binding pocket mutations altered antibiotic-binding affinities, suggesting possible alterations in substrate recognition and transport. CONCLUSIONS: AcrB is a key driver of multidrug resistance in K. pneumoniae, and mutations within its drug-binding pockets can significantly impact protein stability and antibiotic-binding behaviour. Monitoring these structural variations may help predict emerging resistance patterns and guide therapeutic decision-making. IMPORTANCE: Multidrug-resistant Klebsiella pneumoniae infections are a growing clinical threat with limited therapeutic options. By integrating global resistance gene surveillance with structural modelling of AcrB efflux pump variants, this study identifies drug-binding pocket mutations that modulate antibiotic affinity and efflux pump stability. These insights provide a molecular basis for predicting treatment failure, guiding precision antibiotic therapy, and advancing the development of efflux pump inhibitors as adjunctive treatments for drug-resistant Gram-negative infections.
引用
- Dinata R, Baindara P, Chakraborty S, et al. Mutation-driven alterations in the AcrB efflux pump modulate antibiotic resistance in Klebsiella pneumoniae. J Antimicrob Chemother. 2026. PMID: 42554209. doi:10.1093/jac/dkag270
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。